352 medical limited
352 medical limited Company Information
Company Number
NI056235
Website
http://3fivetwo.comRegistered Address
danesfort building, 221 stranmillis road, belfast, BT9 5UB
Industry
General medical practice activities
Specialist medical practice activities
Telephone
02890667878
Next Accounts Due
December 2025
Group Structure
View All
Shareholders
kingsbridge healthcare group limited 100%
352 medical limited Estimated Valuation
Pomanda estimates the enterprise value of 352 MEDICAL LIMITED at £46m based on a Turnover of £58.9m and 0.78x industry multiple (adjusted for size and gross margin).
352 medical limited Estimated Valuation
Pomanda estimates the enterprise value of 352 MEDICAL LIMITED at £15.1m based on an EBITDA of £2.5m and a 6.05x industry multiple (adjusted for size and gross margin).
352 medical limited Estimated Valuation
Pomanda estimates the enterprise value of 352 MEDICAL LIMITED at £19m based on Net Assets of £6.9m and 2.76x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
352 Medical Limited Overview
352 Medical Limited is a live company located in belfast, BT9 5UB with a Companies House number of NI056235. It operates in the hospital activities sector, SIC Code 86101. Founded in August 2005, it's largest shareholder is kingsbridge healthcare group limited with a 100% stake. 352 Medical Limited is a established, large sized company, Pomanda has estimated its turnover at £58.9m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
352 Medical Limited Health Check
Pomanda's financial health check has awarded 352 Medical Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
5 Weak
Size
annual sales of £58.9m, make it larger than the average company (£2.2m)
£58.9m - 352 Medical Limited
£2.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 126%, show it is growing at a faster rate (8.4%)
126% - 352 Medical Limited
8.4% - Industry AVG
Production
with a gross margin of 9.8%, this company has a higher cost of product (40.6%)
9.8% - 352 Medical Limited
40.6% - Industry AVG
Profitability
an operating margin of 4.2% make it less profitable than the average company (10.2%)
4.2% - 352 Medical Limited
10.2% - Industry AVG
Employees
with 60 employees, this is above the industry average (29)
60 - 352 Medical Limited
29 - Industry AVG
Pay Structure
on an average salary of £31.6k, the company has an equivalent pay structure (£31k)
£31.6k - 352 Medical Limited
£31k - Industry AVG
Efficiency
resulting in sales per employee of £981.3k, this is more efficient (£72.9k)
£981.3k - 352 Medical Limited
£72.9k - Industry AVG
Debtor Days
it gets paid by customers after 96 days, this is later than average (28 days)
96 days - 352 Medical Limited
28 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - 352 Medical Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - 352 Medical Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 4 weeks, this is less cash available to meet short term requirements (52 weeks)
4 weeks - 352 Medical Limited
52 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 65.5%, this is a higher level of debt than the average (45.8%)
65.5% - 352 Medical Limited
45.8% - Industry AVG
352 MEDICAL LIMITED financials
352 Medical Limited's latest turnover from March 2024 is £58.9 million and the company has net assets of £6.9 million. According to their latest financial statements, 352 Medical Limited has 60 employees and maintains cash reserves of £25.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 58,877,092 | 40,520,265 | 10,960,503 | 5,083,313 | 4,594,646 | 4,974,145 | 4,171,948 | 14,461,548 | 15,994,700 | 30,657,457 | 40,370,823 | 33,220,254 | 21,053,394 | 8,629,272 | 32,569,522 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 53,090,904 | 36,209,645 | 9,951,009 | 3,488,522 | 3,337,101 | 3,733,811 | 2,789,957 | 12,412,313 | 12,358,388 | 20,111,024 | 27,012,668 | 22,026,112 | 14,050,005 | 4,634,603 | 18,408,963 |
| Gross Profit | 5,786,188 | 4,310,620 | 1,009,494 | 1,594,791 | 1,257,545 | 1,240,334 | 1,381,991 | 2,049,235 | 3,636,312 | 10,546,433 | 13,358,155 | 11,194,142 | 7,003,389 | 3,994,669 | 14,160,559 |
| Admin Expenses | 3,290,505 | 2,451,936 | 510,130 | 750,534 | 603,200 | 357,102 | 2,202,951 | 3,430,255 | 3,234,015 | 10,733,768 | 11,556,515 | 9,343,692 | 6,213,278 | 4,053,760 | 9,160,858 |
| Operating Profit | 2,495,683 | 1,858,684 | 499,364 | 844,257 | 654,345 | 883,232 | -820,960 | -1,381,020 | 402,297 | -187,335 | 1,801,640 | 1,850,450 | 790,111 | -59,091 | 4,999,701 |
| Interest Payable | 0 | 0 | 11,996 | 14,057 | 4,496 | 0 | 13,977 | 0 | 877 | 239,865 | 143,657 | 113,937 | 103,501 | 40,818 | 119,205 |
| Interest Receivable | 488 | 615 | 0 | 0 | 0 | 0 | 0 | 0 | 6,208 | 67,456 | 3,946 | 22,356 | 8,546 | 2,032 | 27,947 |
| Pre-Tax Profit | 2,496,171 | 1,859,299 | 487,368 | 830,200 | 649,849 | -83,734 | -834,937 | -1,430,020 | -93,933 | 561,382 | 1,686,334 | 1,667,845 | 172,614 | -186,830 | 4,912,515 |
| Tax | -266,667 | 0 | 0 | 0 | 0 | 0 | -57,056 | 14,839 | -100,175 | -74,296 | -246,730 | -435,386 | -158,174 | -13,856 | -1,509,435 |
| Profit After Tax | 2,229,504 | 1,859,299 | 487,368 | 830,200 | 649,849 | -83,734 | -891,993 | -1,415,181 | -194,108 | 487,086 | 1,439,604 | 1,232,459 | 14,440 | -200,686 | 3,403,080 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,660,032 | 0 | 0 | 0 | 0 | 0 | 1,441,507 |
| Retained Profit | 2,229,504 | 1,859,299 | 487,368 | 830,200 | 649,849 | -83,734 | -891,993 | -1,415,181 | -3,854,140 | 497,355 | 1,396,244 | 1,232,459 | 14,440 | -200,686 | 1,961,573 |
| Employee Costs | 1,893,437 | 1,128,999 | 725,102 | 890,280 | 901,174 | 781,482 | 24,955 | 54,589 | 454,105 | 10,039,766 | 12,046,288 | 9,192,789 | 5,483,228 | 2,532,081 | 9,588,608 |
| Number Of Employees | 60 | 39 | 19 | 19 | 19 | 19 | 2 | 2 | 13 | 277 | 311 | 228 | 125 | 71 | 128 |
| EBITDA* | 2,495,683 | 1,858,684 | 499,364 | 844,257 | 654,345 | 883,232 | -820,960 | -1,381,020 | 402,297 | 1,081,099 | 2,996,795 | 2,861,179 | 1,448,263 | 323,346 | 5,493,623 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,220,631 | 7,170,062 | 4,935,974 | 4,613,378 | 2,410,656 | 2,658,680 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,284,299 | 2,631,191 | 2,609,167 | 2,919,167 | 0 | 36,213 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49,000 | 906,358 | 286,662 | 49,000 | 68,073 | 67,615 | 134,149 |
| Debtors (Due After 1 year) | 4,456,265 | 2,974,048 | 2,812,150 | 2,586,388 | 1,244,453 | 6,440 | 208,480 | 1,389,776 | 3,166,671 | 0 | 0 | 300,000 | 550,000 | 670,000 | 0 |
| Total Fixed Assets | 4,456,265 | 2,974,048 | 2,812,150 | 2,586,388 | 1,244,453 | 6,440 | 208,480 | 1,389,776 | 3,215,671 | 9,411,288 | 10,087,915 | 7,894,141 | 8,150,618 | 3,148,271 | 2,829,042 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,000 | 469,660 | 627,368 | 409,405 | 173,829 | 5,000 | 5,000 |
| Trade Debtors | 15,509,478 | 11,765,387 | 4,428,534 | 1,424,495 | 894,584 | 1,259,241 | 1,217,759 | 1,865,163 | 4,017,881 | 1,397,378 | 5,018,748 | 4,605,750 | 4,087,167 | 1,917,186 | 1,570,808 |
| Group Debtors | 109 | 109 | 109 | 109 | 109 | 109 | 109 | 109 | 0 | 526,010 | 402,109 | 440,333 | 231,115 | 54,489 | 0 |
| Misc Debtors | 0 | 0 | 310,326 | 299,610 | 260,726 | 537,259 | 378,059 | 177,944 | 35,403 | 1,416,695 | 1,400,088 | 606,341 | 467,623 | 371,014 | 270,139 |
| Cash | 25,256 | 6,362 | 194,694 | 267,913 | 37,973 | 87,923 | 79,413 | 38,150 | 545,991 | 528,071 | 603,999 | 1,786,734 | 959,482 | 1,734,907 | 3,181,384 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 500,000 |
| total current assets | 15,534,843 | 11,771,858 | 4,933,663 | 1,992,127 | 1,193,392 | 1,884,532 | 1,675,340 | 2,081,366 | 4,609,275 | 4,337,814 | 8,052,312 | 7,848,563 | 5,919,216 | 4,082,596 | 5,527,331 |
| total assets | 19,991,108 | 14,745,906 | 7,745,813 | 4,578,515 | 2,437,845 | 1,890,972 | 1,883,820 | 3,471,142 | 7,824,946 | 13,749,102 | 18,140,227 | 15,742,704 | 14,069,834 | 7,230,867 | 8,356,373 |
| Bank overdraft | 0 | 0 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 180,610 | 134,298 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 196,424 | 421,656 | 264,936 | 193,044 | 89,604 | 89,604 |
| Trade Creditors | 0 | 5,684 | 0 | 357,734 | 642,038 | 663,715 | 806,904 | 1,216,147 | 2,266,372 | 2,235,508 | 5,166,641 | 3,692,290 | 3,050,636 | 971,353 | 1,215,647 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 613,092 | 340,810 | 453,291 | 250,626 | 270,379 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39,981 | 64,180 | 88,439 | 71,855 | 0 | 0 |
| other current liabilities | 276,428 | 3,830 | 160 | 398,882 | 311,171 | 392,470 | 158,420 | 444,506 | 1,719,812 | 1,677,179 | 2,924,280 | 3,886,934 | 3,905,133 | 2,272,900 | 2,837,500 |
| total current liabilities | 276,428 | 9,514 | 160 | 756,616 | 953,234 | 1,056,210 | 965,324 | 1,660,653 | 4,599,276 | 4,670,512 | 9,164,346 | 8,183,225 | 7,491,047 | 3,333,857 | 4,142,751 |
| loans | 12,823,698 | 10,074,914 | 4,943,474 | 1,507,088 | 0 | 0 | 0 | 0 | 0 | 1,317,493 | 1,550,770 | 794,994 | 1,030,643 | 489,923 | 567,444 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45,790 | 43,814 | 32,177 | 110,632 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20,983 | 31,985 | 104,539 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,163,948 | 1,304,253 | 2,033,998 | 2,076,200 | 60,215 | 98,620 |
| total long term liabilities | 12,823,698 | 10,074,914 | 4,943,474 | 1,507,088 | 0 | 0 | 0 | 0 | 0 | 2,548,214 | 2,930,822 | 2,965,708 | 3,217,475 | 550,138 | 666,064 |
| total liabilities | 13,100,126 | 10,084,428 | 4,943,634 | 2,263,704 | 953,234 | 1,056,210 | 965,324 | 1,660,653 | 4,599,276 | 7,218,726 | 12,095,168 | 11,148,933 | 10,708,522 | 3,883,995 | 4,808,815 |
| net assets | 6,890,982 | 4,661,478 | 2,802,179 | 2,314,811 | 1,484,611 | 834,762 | 918,496 | 1,810,489 | 3,225,670 | 6,487,370 | 5,991,784 | 4,593,771 | 3,361,312 | 3,346,872 | 3,547,558 |
| total shareholders funds | 6,890,982 | 4,661,478 | 2,802,179 | 2,314,811 | 1,484,611 | 834,762 | 918,496 | 1,810,489 | 3,225,670 | 6,487,370 | 5,991,784 | 4,593,771 | 3,361,312 | 3,346,872 | 3,547,558 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 2,495,683 | 1,858,684 | 499,364 | 844,257 | 654,345 | 883,232 | -820,960 | -1,381,020 | 402,297 | -187,335 | 1,801,640 | 1,850,450 | 790,111 | -59,091 | 4,999,701 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 921,542 | 848,263 | 700,729 | 477,319 | 382,437 | 489,898 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 346,892 | 346,892 | 310,000 | 180,833 | 0 | 4,024 |
| Tax | -266,667 | 0 | 0 | 0 | 0 | 0 | -57,056 | 14,839 | -100,175 | -74,296 | -246,730 | -435,386 | -158,174 | -13,856 | -1,509,435 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10,000 | -459,660 | -157,708 | 217,963 | 235,576 | 168,829 | 0 | 5,000 |
| Debtors | 5,226,308 | 7,188,425 | 3,240,517 | 1,910,730 | 596,823 | -1,358 | -1,628,585 | -3,786,963 | 3,879,872 | -3,480,862 | 868,521 | 616,519 | 2,323,216 | 1,171,742 | 1,840,947 |
| Creditors | -5,684 | 5,684 | -357,734 | -284,304 | -21,677 | -143,189 | -409,243 | -1,050,225 | 30,864 | -2,931,133 | 1,474,351 | 641,654 | 2,079,283 | -244,294 | 1,215,647 |
| Accruals and Deferred Income | 272,598 | 3,670 | -398,722 | 87,711 | -81,299 | 234,050 | -286,086 | -1,275,306 | 42,633 | -1,247,101 | -962,654 | -18,199 | 1,632,233 | -564,600 | 2,837,500 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,163,948 | -140,305 | -729,745 | -42,202 | 2,015,985 | -38,405 | 98,620 |
| Cash flow from operations | -2,730,378 | -5,320,387 | -3,497,609 | -1,263,066 | -45,454 | 975,451 | 55,240 | 105,251 | -4,208,541 | 326,834 | 1,445,533 | 2,154,951 | 4,525,545 | -1,709,551 | 6,290,008 |
| Investing Activities | |||||||||||||||
| capital expenditure | 0 | -263,823 | -4,445,956 | -988,331 | -4,070,849 | -179,414 | -2,718,005 | ||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -49,000 | -857,358 | 619,696 | 237,662 | -19,073 | 458 | -66,534 | 134,149 |
| cash flow from investments | 857,358 | -883,519 | -4,683,618 | -969,258 | -4,071,307 | -112,880 | -2,852,154 | ||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -196,424 | -225,232 | 156,720 | 71,892 | 103,440 | 0 | 89,604 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -613,092 | 272,282 | -112,481 | 202,665 | -19,753 | 270,379 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 2,748,784 | 5,131,440 | 3,436,386 | 1,507,088 | 0 | 0 | 0 | 0 | -1,317,493 | -233,277 | 755,776 | -235,649 | 540,720 | -77,521 | 567,444 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -85,771 | -22,223 | -12,622 | -61,871 | 182,487 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20,983 | -11,002 | -72,554 | 104,539 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 488 | 615 | -11,996 | -14,057 | -4,496 | 0 | -13,977 | 0 | 5,331 | -172,409 | -139,711 | -91,581 | -94,955 | -38,786 | -91,258 |
| cash flow from financing | 2,749,272 | 5,132,055 | 3,424,390 | 1,493,031 | -4,496 | 0 | -13,977 | -613,092 | -750,618 | -778,393 | 892,043 | -232,423 | 1,002,071 | -116,307 | 2,151,775 |
| cash and cash equivalents | |||||||||||||||
| cash | 18,894 | -188,332 | -73,219 | 229,940 | -49,950 | 8,510 | 41,263 | -507,841 | 17,920 | -75,928 | -1,182,735 | 827,252 | -775,425 | -1,446,477 | 3,181,384 |
| overdraft | 0 | 0 | 0 | -25 | 0 | 25 | 0 | 0 | -180,610 | 46,312 | 134,298 | 0 | 0 | 0 | 0 |
| change in cash | 18,894 | -188,332 | -73,219 | 229,965 | -49,950 | 8,485 | 41,263 | -507,841 | 198,530 | -122,240 | -1,317,033 | 827,252 | -775,425 | -1,446,477 | 3,181,384 |
352 medical limited Credit Report and Business Information
352 Medical Limited Competitor Analysis
Perform a competitor analysis for 352 medical limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in BT9 area or any other competitors across 12 key performance metrics.
352 medical limited Ownership
352 MEDICAL LIMITED group structure
352 Medical Limited has 3 subsidiary companies.
Ultimate parent company
1 parent
352 MEDICAL LIMITED
NI056235
3 subsidiaries
352 medical limited directors
352 Medical Limited currently has 3 directors. The longest serving directors include Mr Ashok Songra (Oct 2005) and Dr Suresh Tharmaratnam (Oct 2005).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Ashok Songra | United Kingdom | 64 years | Oct 2005 | - | Director |
| Dr Suresh Tharmaratnam | Northern Ireland | 61 years | Oct 2005 | - | Director |
| Mr Jeremy MacArtney | Northern Ireland | 62 years | Jun 2011 | - | Director |
P&L
March 2024turnover
58.9m
+45%
operating profit
2.5m
+34%
gross margin
9.9%
-7.62%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
6.9m
+0.48%
total assets
20m
+0.36%
cash
25.3k
+2.97%
net assets
Total assets minus all liabilities
352 medical limited company details
company number
NI056235
Type
Private limited with Share Capital
industry
86101 - Hospital activities
86210 - General medical practice activities
86220 - Specialist medical practice activities
incorporation date
August 2005
age
19
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
BAKER TILLY MOONEY MOORE
address
danesfort building, 221 stranmillis road, belfast, BT9 5UB
Bank
SANTANDER UK PLC, SANTANDER UK PLC
Legal Advisor
A&L GOODBODY
352 medical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 10 charges/mortgages relating to 352 medical limited. Currently there are 0 open charges and 10 have been satisfied in the past.
352 medical limited Companies House Filings - See Documents
| date | description | view/download |
|---|
